Population characteristics of biological systems influenced by multicomponent random and uniform variation
- PMID: 1535443
- DOI: 10.1023/a:1015838802045
Population characteristics of biological systems influenced by multicomponent random and uniform variation
Abstract
The total variability associated with the pharmacokinetic disposition of seven therapeutic agents was decomposed into its source components. After differentiating and isolating random components from fixed uniform components of variance, the proportional contribution of random intersubject and intrasubject variance was evaluated. Statistical analysis utilized a mixed-effects probabilistic model which incorporated both random effects and fixed day-to-day effects. In some cases, time-within-day diurnal effects were also incorporated. While significant intersubject effects were found for all seven drugs studied, three of them were characterized by predominant intrasubject variance. Since intrasubject variance represents a measure of the stability of drug disposition, characterization of its relative magnitude is fundamentally important in assessing the therapeutic consequences of a given treatment at any given time. Significant diurnal effects were found which were strikingly invariant.
Similar articles
-
Dose proportionality and population characteristics of oral fadrozole hydrochloride, an aromatase inhibitor, in postmenopausal women.Pharm Res. 1993 Dec;10(12):1760-4. doi: 10.1023/a:1018930316215. Pharm Res. 1993. PMID: 8302763 Clinical Trial.
-
The pharmacodynamic inhibition of estrogen synthesis by fadrozole, an aromatase inhibitor, and its pharmacokinetic disposition.J Clin Endocrinol Metab. 1990 Nov;71(5):1349-5. doi: 10.1210/jcem-71-5-1349. J Clin Endocrinol Metab. 1990. PMID: 2146284
-
Intra- and intersubject variability: mixed-effects statistical analysis of repeated doses of an angiotensin converting enzyme inhibitor, CGS 16617.Pharm Res. 1989 Apr;6(4):328-31. doi: 10.1023/a:1015954609527. Pharm Res. 1989. PMID: 2748520
-
Inter- and intrasubject variation of digoxin renal clearance in normal adult males.Drug Intell Clin Pharm. 1988 Jul-Aug;22(7-8):562-7. doi: 10.1177/106002808802200708. Drug Intell Clin Pharm. 1988. PMID: 3416739
-
A study of fadrozole, a new aromatase inhibitor, in postmenopausal women with advanced metastatic breast cancer.J Clin Oncol. 1992 Jan;10(1):111-6. doi: 10.1200/JCO.1992.10.1.111. J Clin Oncol. 1992. PMID: 1530798 Clinical Trial.
Cited by
-
Dose proportionality and population characteristics of oral fadrozole hydrochloride, an aromatase inhibitor, in postmenopausal women.Pharm Res. 1993 Dec;10(12):1760-4. doi: 10.1023/a:1018930316215. Pharm Res. 1993. PMID: 8302763 Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources